Antihemophilic Factor (Recombinant), Plasma/Albumin Free (Xyntha, Xyntha Solofuse)
Antihemophilic Factor (Recombinant), Plasma/Albumin Free is an FDA-licensed reference biologic from Wyeth Pharmaceuticals LLC. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2008
Reference approved
Reference product
Xyntha, Xyntha Solofuse Antihemophilic Factor (Recombinant), Plasma/Albumin Free
Wyeth Pharmaceuticals LLC
- Approved
- Feb 21, 2008
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Antihemophilic Factor (Recombinant), Plasma/Albumin Free, in chronological order.
Reference approval
Approval date of the reference Antihemophilic Factor (Recombinant), Plasma/Albumin Free product.
18 yr 7 mo ago
Frequently asked questions
Are there biosimilars approved for Antihemophilic Factor (Recombinant), Plasma/Albumin Free (Xyntha, Xyntha Solofuse)?
No 351(k) biosimilars or interchangeable biosimilars referencing Antihemophilic Factor (Recombinant), Plasma/Albumin Free are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.